Crispr stock forecast 2025
Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $89.77. The forecasts range from a low of $42.00 to a high of $220.00. The ...Find the latest CRISPR Therapeutics AG CRSP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range …Web
Did you know?
Jan 8, 2022 · Shares of CRISPR Therapeutics ( CRSP -7.40%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ... Find real-time UPH - UpHealth Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter)-$0.48: Annual revenue (last year) $158.8M: Annual profit ...Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing.Tattooed Chef Stock Forecast, TTCF stock price prediction. Price target in 14 days: 0.0497 USD. ... Tattooed Chef Inc Stock Price Forecast for 2025: January 2025 ...
Exro Technologies Stock Forecast, EXROF stock price prediction. Price target in 14 days: 1.129 USD. ... Exro Technologies Inc Stock Price Forecast for 2025: January ... 2.82%. $3.25B. TWST | Complete Twist Bioscience Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find real-time ME - 23andMe Holding Co. stock quotes, company profile, news and forecasts from CNN Business.NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.CRSP stock has rallied from $34 to $107 off the recent bottom compared to the S&P which moved 60% over the same period, with the resumption of economic activities as lockdowns are gradually lifted ...
It is projected to grow at a compounded annual growth rate of 8% to be valued at $14 billion by 2030. Under the terms of the deal, Vertex paid CRISPR $100 million up front for those rights and ...Get a real-time CRISPR Therapeutics AG (CRSP) stock price quote with breaking news, financials, statistics, charts and more. Get a real-time ... the average rating for CRSP stock is "Buy." The 12-month stock price forecast is $69.88, which is an increase of 1.79% from the latest price. Price Target. $69.88 (1.79% upside) Analyst ... ….
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Crispr stock forecast 2025. Possible cause: Not clear crispr stock forecast 2025.
Find real-time NOK - Nokia Oyj stock quotes, company profile, news and forecasts from CNN Business.Get a real-time CRISPR Therapeutics AG (CRSP) stock price quote with breaking news, financials, statistics, charts and more. Get a real-time ... the average rating for CRSP stock is "Buy." The 12-month stock price forecast is $69.88, which is an increase of 1.79% from the latest price. Price Target. $69.88 (1.79% upside) Analyst ...
Dec 1, 2023 · So, when comparing one stock to another in a different industry, it's best make relative comparisons to that stock's respective industry values. -240.84% -224.88% Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Altimmune Inc have a median target of 16.00, with a high estimate of 35.00 and a low estimate of 8.00. The median ...
itko stock The stock price of CRISPR Therapeutics, a biotechnology gene editing company focused on developing gene-based medicines for human diseases, reached an all-time high of $210 in January of this year ...Out of 197 instances in the last 4 years that CRISPR Therapeutics (CRSP) stock saw a 5-day decline of 7.3% or more, 112 of them resulted in CRSP stock rising over the subsequent one month period ... northern myanmarslf Jan 12, 2019 · But CRISPR Therapeutics could also have another product on the market in 10 years. The biotech plans to begin an early-stage clinical study of allogeneic CAR-T therapy CTX110 in the first half of ... groundfloor real estate investing reviews Stock Price Forecast. The 1 analysts offering 12-month price forecasts for UpHealth Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50.CRISPR Therapeutics AG (CRSP) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including …Web best mortgage lenders in raleigh ncvanguard high yield corporate admiralrmd on an inherited ira Clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 is a gene-editing technology causing a major upheaval in biomedical research. It makes it possible to correct errors in the genome and turn on or off genes in cells and organisms quickly, cheaply and with relative ease. It has a number of laboratory applications including rapid ...CRISPR Therapeutics. Market Cap. $6B. Today's Change. (4.32%) $2.92. Current Price. $70.49. Price as of November 22, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may ... pulte stock price See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Net-net, stable profitability for Alibaba in the intermediate term is a reasonable assumption as I mentioned. My valuation implies that Alibaba's shares will be worth $138 in 2025, and this ... www.canpayappassurant renters insurance costshv dividend history We asked three Motley Fool contributors to identify biotech stocks they think could deliver 5x returns by 2030. Here's why they chose CRISPR Therapeutics ( CRSP -1.82%), Maravai LifeSciences ...